Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".

Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY.

Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752. [Epub ahead of print]

PMID:
28353492
2.

Green Sputum From a Patient With Primary Sclerosing Cholangitis.

Thompson G, Sanchez W, Simonetto DA.

Clin Gastroenterol Hepatol. 2017 Feb 20. pii: S1542-3565(17)30188-X. doi: 10.1016/j.cgh.2017.02.009. [Epub ahead of print] No abstract available.

PMID:
28223202
3.

Surveillance for liver complications after the Fontan procedure.

Hilscher MB, Johnson JN, Cetta F, Driscoll DJ, Poterucha JJ, Sanchez W, Connolly HM, Kamath PS.

Congenit Heart Dis. 2017 Mar;12(2):124-132. doi: 10.1111/chd.12446. Epub 2017 Jan 31. Review.

PMID:
28140526
4.

Attenuation measuring ultrasound shearwave elastography and in vivo application in post-transplant liver patients.

Nenadic IZ, Qiang B, Urban MW, Zhao H, Sanchez W, Greenleaf JF, Chen S.

Phys Med Biol. 2017 Jan 21;62(2):484-500. doi: 10.1088/1361-6560/aa4f6f. Epub 2016 Dec 21.

PMID:
28000623
5.

Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.

Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY.

JAMA Oncol. 2017 Apr 1;3(4):493-500. doi: 10.1001/jamaoncol.2016.5116.

PMID:
27838698
6.

Longterm clinical and radiological follow-up of living liver donors.

Darwish Murad S, Fidler JL, Poterucha JJ, Sanchez W, Jowsey SG, Nagorney D, Rosen CB, Heimbach JK.

Liver Transpl. 2016 Jul;22(7):934-42. doi: 10.1002/lt.24442.

PMID:
27144969
7.

Reply.

Singh JA, Saag KS, Louis Bridges S Jr, Sanchez W, McAlindon T.

Arthritis Rheumatol. 2016 May;68(5):1316-8. doi: 10.1002/art.39632. No abstract available.

8.

Reply.

Singh JA, Saag KS, Louis Bridges S Jr, Sanchez W, McAlindon T.

Arthritis Care Res (Hoboken). 2016 May;68(5):725-6. doi: 10.1002/acr.22862. No abstract available.

9.

Safety and Outcomes of Percutaneous Biopsy of 61 Hepatic Adenomas.

Doolittle DA, Atwell TD, Sanchez W, Mounajjed T, Hough DM, Schmit GD, Kurup AN.

AJR Am J Roentgenol. 2016 Apr;206(4):871-6. doi: 10.2214/AJR.15.15301. Epub 2016 Feb 11.

PMID:
26866339
10.

Performance of 2-Dimensional Ultrasound Shear Wave Elastography in Liver Fibrosis Detection Using Magnetic Resonance Elastography as the Reference Standard: A Pilot Study.

Song P, Mellema DC, Sheedy SP, Meixner DD, Karshen RM, Urban MW, Manduca A, Sanchez W, Callstrom MR, Greenleaf JF, Chen S.

J Ultrasound Med. 2016 Feb;35(2):401-12. doi: 10.7863/ultra.15.03036. Epub 2016 Jan 18.

11.

Response to Fibrosis progression in patients treated for hepatitis C recurrence.

Dhanasekaran R, Sanchez W, Charlton M.

Liver Int. 2015 Dec;35(12):2625. doi: 10.1111/liv.12969. No abstract available.

PMID:
26386267
12.

The shear effort of measurement of portal hypertension.

Sanchez W, Kamath PS.

Hepatology. 2015 Dec;62(6):1909-11. doi: 10.1002/hep.28027. Epub 2015 Sep 1. No abstract available.

PMID:
26239925
13.

Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.

Dhanasekaran R, Sanchez W, Mounajjed T, Wiesner RH, Watt KD, Charlton MR.

Liver Int. 2015 Nov;35(11):2433-41. doi: 10.1111/liv.12890. Epub 2015 Jul 1.

PMID:
26058570
14.

The $64,000 question.

Keller AS, Schiavo D, Wingo M, Ernste F, Sanchez W.

J Hosp Med. 2015 Feb;10(2):112-5. doi: 10.1002/jhm.2304. Epub 2014 Dec 24. No abstract available.

PMID:
25537658
15.

A new clinically based staging system for perihilar cholangiocarcinoma.

Chaiteerakij R, Harmsen WS, Marrero CR, Aboelsoud MM, Ndzengue A, Kaiya J, Therneau TM, Sanchez W, Gores GJ, Roberts LR.

Am J Gastroenterol. 2014 Dec;109(12):1881-90. doi: 10.1038/ajg.2014.327. Epub 2014 Nov 11.

16.

Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.

Terzi E, Ray Kim W, Sanchez W, Charlton MR, Schmeltzer P, Gores GJ, Andrews JC, Smyrk TC, Heimbach JK.

Liver Transpl. 2015 Feb;21(2):248-57. doi: 10.1002/lt.24041.

17.

Noninvasive assessment of liver fibrosis using ultrasound-based shear wave measurement and comparison to magnetic resonance elastography.

Zhao H, Chen J, Meixner DD, Xie H, Shamdasani V, Zhou S, Robert JL, Urban MW, Sanchez W, Callstrom MR, Ehman RL, Greenleaf JF, Chen S.

J Ultrasound Med. 2014 Sep;33(9):1597-604. doi: 10.7863/ultra.33.9.1597.

18.

Chemopreventive strategies in hepatocellular carcinoma.

Singh S, Singh PP, Roberts LR, Sanchez W.

Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):45-54. doi: 10.1038/nrgastro.2013.143. Epub 2013 Aug 13. Review.

19.

Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.

Singh S, Singh PP, Singh AG, Murad MH, Sanchez W.

Am J Gastroenterol. 2013 Jun;108(6):881-91; quiz 892. doi: 10.1038/ajg.2013.5. Epub 2013 Feb 5. Review.

PMID:
23381014
20.

Chinese skullcap in move free arthritis supplement causes drug induced liver injury and pulmonary infiltrates.

Dhanasekaran R, Owens V, Sanchez W.

Case Reports Hepatol. 2013;2013:965092. doi: 10.1155/2013/965092. Epub 2013 Apr 14.

Supplemental Content

Loading ...
Support Center